It is, therefore, tempting to speculate that the chemo sensitizing effects observed in small cell lung cancer by this compound are also through an inhibition of TRIM25-mediated 14-3-3σ degradation, leading to an impaired degradation of p53 by Mdm2. The gene discussed is MDM2; the disease is small cell lung carcinoma.